Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Levin

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Nature|January 23, 1992
9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alphaA A Levin, L J Sturzenbecker, S Kazmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Retinoid X receptor-selective ligands produce malformations in Xenopus embryosS Minucci, J P Saint-Jeannet, R Toyama, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2001
Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in ratsR S Geary, T A Watanabe, L Truong, et al.
Antisense & Nucleic Acid Drug Development|November 18, 2000
Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotide following inhalation delivery to lung in miceM V Templin, A A Levin, M J Graham, et al.
Journal of Medicinal Chemistry|June 23, 1995
Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activityM Alam, V Zhestkov, B P Sani, et al.
Biochemistry|June 4, 1991
Retinoic acid receptor belongs to a subclass of nuclear receptors that do not form "docking" complexes with hsp90F C Dalman, L J Sturzenbecker, A A Levin, et al.
Journal of Pharmaceutical Sciences|February 13, 2001
Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha-ras mRNA in mouse and monkeyR Z Yu, R S Geary, J M Leeds, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)J M Glover, J M Leeds, T G Mant, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 1996
4-Oxoretinol, a new natural ligand and transactivator of the retinoic acid receptorsC C Achkar, F Derguini, B Blumberg, et al.
Scientific Reports|May 15, 2023
Assessment of experimental OpenCV tracking algorithms for ultrasound videosA A Levin, D D Klimov, A A Nechunaev, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Nature|January 23, 1992
9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alphaA A Levin, L J Sturzenbecker, S Kazmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Retinoid X receptor-selective ligands produce malformations in Xenopus embryosS Minucci, J P Saint-Jeannet, R Toyama, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2001
Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in ratsR S Geary, T A Watanabe, L Truong, et al.
Antisense & Nucleic Acid Drug Development|November 18, 2000
Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotide following inhalation delivery to lung in miceM V Templin, A A Levin, M J Graham, et al.
Journal of Medicinal Chemistry|June 23, 1995
Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activityM Alam, V Zhestkov, B P Sani, et al.
Biochemistry|June 4, 1991
Retinoic acid receptor belongs to a subclass of nuclear receptors that do not form "docking" complexes with hsp90F C Dalman, L J Sturzenbecker, A A Levin, et al.
Journal of Pharmaceutical Sciences|February 13, 2001
Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha-ras mRNA in mouse and monkeyR Z Yu, R S Geary, J M Leeds, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)J M Glover, J M Leeds, T G Mant, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 1996
4-Oxoretinol, a new natural ligand and transactivator of the retinoic acid receptorsC C Achkar, F Derguini, B Blumberg, et al.
Scientific Reports|May 15, 2023
Assessment of experimental OpenCV tracking algorithms for ultrasound videosA A Levin, D D Klimov, A A Nechunaev, et al.
Pageof 9